High-Dose Daptomycin Is Well Tolerated via 2-Minute IV Push Administration
© The Author(s) 2019..
BACKGROUND: The purpose of this study was to evaluate the safety of administering high-dose daptomycin (HDD; > 6 mg/kg actual body weight) as a 2-minute intravenous (IV) push (IVP) compared to traditional 30-minute IV piggyback (IVPB) infusion.
METHODS: Retrospective cohort study comparing patients receiving HDD as an IVP or IVPB infusion. The primary outcome was the proportion of patients with a documented infusion-related reaction (IRR) to daptomycin.
RESULTS: Three hundred patients were included in the final analysis, 200 patients received IVP, and 100 patients received IVPB representing a total of 1697 administrations. Median (IQR) daptomycin dose was IVP 700 mg (550-900) and IVPB 700 mg (600-900), with mg/kg doses of 8.2 (7.9-10) and 8.3 (8-10), respectively. After adjudication, IRR occurred in 1% of subjects in each treatment group.
CONCLUSIONS: This study provides data in more than 1100 administrations of HDD administered via IVP. Infusion-related reactions were documented in 1% of patients regardless of infusion method, suggesting comparable safety to traditional infusion methods. This practice may be useful during fluid shortage and in the outpatient setting.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:56 |
|---|---|
| Enthalten in: |
Hospital pharmacy - 56(2021), 4 vom: 20. Aug., Seite 328-331 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Gill, Christian M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Daptomycin |
|---|
| Anmerkungen: |
Date Revised 02.08.2022 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1177/0018578719897076 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM329251597 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM329251597 | ||
| 003 | DE-627 | ||
| 005 | 20231225204718.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/0018578719897076 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1097.xml |
| 035 | |a (DE-627)NLM329251597 | ||
| 035 | |a (NLM)34381269 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gill, Christian M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a High-Dose Daptomycin Is Well Tolerated via 2-Minute IV Push Administration |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 02.08.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © The Author(s) 2019. | ||
| 520 | |a BACKGROUND: The purpose of this study was to evaluate the safety of administering high-dose daptomycin (HDD; > 6 mg/kg actual body weight) as a 2-minute intravenous (IV) push (IVP) compared to traditional 30-minute IV piggyback (IVPB) infusion | ||
| 520 | |a METHODS: Retrospective cohort study comparing patients receiving HDD as an IVP or IVPB infusion. The primary outcome was the proportion of patients with a documented infusion-related reaction (IRR) to daptomycin | ||
| 520 | |a RESULTS: Three hundred patients were included in the final analysis, 200 patients received IVP, and 100 patients received IVPB representing a total of 1697 administrations. Median (IQR) daptomycin dose was IVP 700 mg (550-900) and IVPB 700 mg (600-900), with mg/kg doses of 8.2 (7.9-10) and 8.3 (8-10), respectively. After adjudication, IRR occurred in 1% of subjects in each treatment group | ||
| 520 | |a CONCLUSIONS: This study provides data in more than 1100 administrations of HDD administered via IVP. Infusion-related reactions were documented in 1% of patients regardless of infusion method, suggesting comparable safety to traditional infusion methods. This practice may be useful during fluid shortage and in the outpatient setting | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a daptomycin | |
| 650 | 4 | |a infusion intravenous | |
| 650 | 4 | |a medication safety | |
| 650 | 4 | |a pharmaceutical preparations | |
| 700 | 1 | |a Kenney, Rachel M |e verfasserin |4 aut | |
| 700 | 1 | |a Makowski, Charles T |e verfasserin |4 aut | |
| 700 | 1 | |a Davis, Susan L |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Hospital pharmacy |d 1975 |g 56(2021), 4 vom: 20. Aug., Seite 328-331 |w (DE-627)NLM001930168 |x 0018-5787 |7 nnns |
| 773 | 1 | 8 | |g volume:56 |g year:2021 |g number:4 |g day:20 |g month:08 |g pages:328-331 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1177/0018578719897076 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 56 |j 2021 |e 4 |b 20 |c 08 |h 328-331 | ||